Clinical Trial Update: Efficacy Study of ABR-215050 to Treat Prostate Cancer [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 efficacy study evaluating ABR-215050 for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ABR-215050

Snippet

Sponsor: Active Biotech AB | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED